Literature DB >> 6297202

Gonadotrophin-secretion in adrenocortical insufficiency: impact of glucocorticoid substitution.

H Vierhapper, W Waldhäusl, P Nowotny.   

Abstract

In patients with deficient endogenous glucocorticoid production due to primary adrenal insufficiency (n = 4) or bilateral adrenalectomy (n = 2) a rise in LRH-stimulated concentrations of LH was seen following withdrawal of substitution therapy for 84 h. Consecutive re-administration of glucocorticoids (dexamethasone 2.0 mg/day for 3 days) resulted in increased basal concentrations of LH and FSH and a diminished secretory response of LH upon iv LRH (100 micrograms). Five patients substituted with glucocorticoids because of adrenocortical insufficiency presented upon the administration of exogenous ACTH1-24 with unchanged basal and LRH-stimulated concentrations of LH and FSH as compared to a placebo experiment. These data suggest that the withdrawal and subsequent re-administration of gluco-corticoid substitution alters basal and stimulated concentrations of gonadotrophins in patients with adrenocortical insufficiency, thus providing evidence for the importance of adequate glucocorticoid supply in the regulation of gonadotrophin secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6297202     DOI: 10.1530/acta.0.1010580

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Gynecomastia associated with isolated ACTH deficiency.

Authors:  A Shimatsu; Y Suzuki; S Tanaka
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

2.  Stimulation of gonadal steroid synthesis by chronic excess of adrenocorticotropin in patients with adrenocortical insufficiency.

Authors:  H Vierhapper; P Nowotny; W Waldhäusl
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Lack of gonadotropic response to pulsatile gonadotropin-releasing hormone in isolated hypogonadotropic hypogonadism associated to congenital adrenal hypoplasia.

Authors:  P Bovet; M J Reymond; F Rey; F Gomez
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.